Back to Search
JONATHON FRIEDBERG, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1821016833IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
224820(NY)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
224820(NY)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
224820(NY)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
HARVARD MEDICAL SCHOOL
Class of 1994
Research & Publications (20)
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.
PMID 19519691·Br J Haematol·2009
3-trial
Follicular lymphoma in the United States: first report of the national LymphoCare study.
PMID 19204203·J Clin Oncol·2009
8-other
Treatment of follicular non-Hodgkin's lymphoma: the old and the new.
PMID 18760706·Semin Hematol·2008
6-review
Targeting the follicular lymphoma microenvironment through blockade of TNFalpha with etanercept.
PMID 18464109·Leuk Lymphoma·2008
3-trial
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
PMID 18182663·J Clin Oncol·2008
3-trial
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma.
PMID 16916488·Curr Treat Options Oncol·2006
6-review
Unique toxicities and resistance mechanisms associated with monoclonal antibody therapy.
PMID 16304399·Hematology Am Soc Hematol Educ Program·2005
8-other
Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity.
PMID 15358617·Blood·2005
3-trial
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison.
PMID 15061202·Leuk Lymphoma·2004
3-trial
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma.
PMID 14748653·Expert Rev Anticancer Ther·2004
6-review
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.
PMID 14654078·Leuk Res·2004
3-trial
Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.
PMID 13130315·Bone Marrow Transplant·2003
3-trial
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity.
PMID 12942565·Cancer·2003
3-trial
Challenges and recommendations for blinding in behavioral interventions illustrated using a case study of a behavioral intervention to lower blood pressure.
PMID 19525084·Patient Educ Couns·2010
6-review
Relationship between forgiveness and psychological and physiological indices in cardiac patients.
PMID 19229635·Int J Behav Med·2009
8-other
The impact of forgiveness on cardiovascular reactivity and recovery.
PMID 17466400·Int J Psychophysiol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE, BOX MED
ROCHESTER, NY 14642 - Phone
- (585) 275-0784
Quick Facts
- NPI
- 1821016833
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile